Avoro Capital Advisors LLC Seagen Inc. Transaction History

Avoro Capital Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$187.64 - $206.25 $7.94 Million - $8.72 Million	-42,300 Reduced 2.35%	1,759,606 $339 Million
Q1 2023 May 15, 2023	SELL	$127.59 - $203.08 $10.6 Million - $16.9 Million	-83,094 Reduced 4.41%	1,801,906 $365 Million
Q4 2022 Feb 14, 2023	BUY	$117.37 - $139.17 $2.35 Million - $2.78 Million	20,000 Added 1.07%	1,885,000 $242 Million
Q3 2022 Nov 14, 2022	BUY	$135.27 - $180.11 $46 Million - $61.2 Million	340,000 Added 22.3%	1,865,000 $255 Million
Q2 2022 Aug 15, 2022	BUY	$108.81 - $179.33 $22.9 Million - $37.7 Million	210,000 Added 15.97%	1,525,000 $270 Million

Q1 2022 May 16, 2022	BUY	$119.61 - $157.85 $157 Million - $208 Million	1,315,000 New	1,315,000 $189 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Avoro Capital Advisors LLC with notifications on news.